SCHEMBL10195068

SCHEMBL10195068

Cc1ccc(Oc2ccc(Cl)cc2Cl)cc1C1=C(O)C(C)(C)OC(C)(C)C1=O

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LPAR2 Q9HBW0 3/20 0.38
MRGPRX4 Q96LA9 2/20 0.38
FFAR1 O14842 3/20 0.37
TDP1 Q9NUW8 1/20 0.37
NR1I2 O75469 1/20 0.36
LMNA P02545 1/20 0.36
TTR P02766 1/20 0.36
PGR P06401 1/20 0.36
HSP90AA1 P07900 1/20 0.36
ADORA3 P0DMS8 1/20 0.36
MAPT P10636 1/20 0.36
HSPA5 P11021 1/20 0.36
HPGD P15428 1/20 0.36
CBR1 P16152 1/20 0.36
TBXA2R P21731 1/20 0.36
SLC6A2 P23975 1/20 0.36
AGTR1 P30556 1/20 0.36
SLC6A3 Q01959 1/20 0.36
PARG Q86W56 1/20 0.36
PNLIP P16233 2/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10195067 0.88 MAOA (0.40) LMNA
SCHEMBL10195097 0.88 HTR2A (0.39) LPAR2MRGPRX4FFAR1TDP1NR1I2
SCHEMBL10192892 0.86 HTR2A (0.40) LPAR2MRGPRX4FFAR1TDP1NR1I2
SCHEMBL10195057 0.85 MRGPRX4 (0.37) LPAR2MRGPRX4FFAR1TDP1NR1I2
SCHEMBL13219189 0.84 ACACB (0.38) LMNAHSP90AA1MAPT
SCHEMBL10195307 0.82 SLC6A4 (0.36) SLC6A2SLC6A3PARGHTR2ASLC6A4
SCHEMBL16181151 0.81 HTR2A (0.36) MRGPRX4LMNAHSP90AA1MAPTPARG
SCHEMBL12129064 0.80 ACACB (0.40) MAPT
SCHEMBL16351669 0.78 SLC6A4 (0.34) MRGPRX4MAPTSLC6A2SLC6A3PARG
SCHEMBL10195115 0.78 SLC6A4 (0.41) SLC6A2SLC6A3PNLIPHIF1AHTR2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2387569-B1 HERBCIDES SYNGENTA LTD (GB) 2016-06-15 EP disclosed
US-20140378305-A1 NOVEL HERBICIDES SYNGENTA LIMITED (GB) 2014-12-25 US disclosed
US-20140378305-A1 NOVEL HERBICIDES SYNGENTA LIMITED (GB) 2014-12-25 US disclosed
US-8865623-B2 Herbicidally active cyclic diones and derivatives thereof, processes for their preparation, compositions, and method of controlling weeds SYNGENTA LIMITED (GB) 2014-10-21 US disclosed
US-8865623-B2 Herbicidally active cyclic diones and derivatives thereof, processes for their preparation, compositions, and method of controlling weeds SYNGENTA LIMITED (GB) 2014-10-21 US disclosed
US-20120021907-A1 NOVEL HERBICIDES SYNGENTA CROP PROTECTION LLC (US) 2012-01-26 US disclosed
US-20120021907-A1 NOVEL HERBICIDES SYNGENTA CROP PROTECTION LLC (US) 2012-01-26 US disclosed
WO-2010081755-A1 NOVEL HERBICIDES SYNGENTA LIMITED (GB) 2010-07-22 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140378305-A1 NOVEL HERBICIDES DDT, CYP4X1, CYP1B1 LPAR2 2699/4885MRGPRX4 1286/4885FFAR1 1022/4885
US-20120021907-A1 NOVEL HERBICIDES DDT, CYP4X1, CYP1B1 LPAR2 2503/4885MRGPRX4 1260/4885FFAR1 752/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.